The Challenge of Quantifying Vitality: Standardizing Intrinsic Capacity as a New Frontier in Geroscience and Healthy Aging

The pursuit of human health has long been characterized by a reactionary paradigm, defined primarily by the absence of infirmity rather than the presence of robust physiological function. In clinical settings, a patient is often deemed "healthy" simply because they do not meet the diagnostic criteria for a specific disease. However, as global populations age and the field of geroscience—the study of the biology of aging and its relationship to chronic disease—advances, this binary definition is proving inadequate. To develop effective therapies that target the aging process itself, health must be pinned down, operationalized, and measured with the same rigor applied to pathology. While numerous international bodies have offered guidelines to this end, these frameworks have been interpreted in countless ways by the scientific community, leading to a fragmented landscape of data that complicates the comparison of studies and the validation of new interventions.

The transition toward a proactive measurement of health reached a milestone with the World Health Organization’s (WHO) introduction of the "healthy ageing" framework. Central to this framework is the concept of Intrinsic Capacity (IC), defined as the composite of all physical and mental capacities that an individual can draw upon. Unlike traditional models that focus on what an individual has lost to disease, IC focuses on the functional reserves an individual retains. This shift represents the first time in human history that science has moved toward measuring health directly. Yet, despite the transformative potential of IC for research and clinical practice, the lack of a standardized methodology for its assessment poses a significant risk to the credibility and progress of longevity science.

The Conceptual Architecture of Intrinsic Capacity

Intrinsic capacity is not a monolithic metric but a multidimensional construct. In 2017, a group of WHO-affiliated investigators and geriatricians identified five specific subdomains as being pivotal to an individual’s functional status: locomotor, cognitive, sensory, psychological, and vitality. These domains were selected because they are collectively predictive of an older person’s ability to remain independent and resilient in the face of physiological stressors.

The first four domains—locomotor (mobility and balance), cognitive (memory and executive function), sensory (vision and hearing), and psychological (emotional regulation and resilience)—are relatively straightforward to measure using established clinical tools. For example, locomotor capacity is often assessed via gait speed or the Short Physical Performance Battery (SPPB), while cognitive capacity utilizes standardized tests like the Mini-Mental State Examination (MMSE). However, the fifth domain, vitality, has proven to be the most elusive and complex to standardize.

Vitality is conceptualized as the underlying biological "engine" that maintains homeostasis and fuels the other four capacities. It describes the biological attributes required to sustain life and repair damage at a cellular level. When the WHO-affiliated researchers analyzed biological profiles to define vitality, they identified a cluster of biomarkers that consistently correlated with functional decline. These included dehydroepiandrosterone sulfate (DHEAS), insulin-like growth factor 1 (IGF-1), hemoglobin levels, forced expiratory volume (FEV1), and grip strength. While these measures have been replicated in various cohorts across multiple continents, the specific combination and weighting of these markers remain a subject of intense debate.

The Crisis of Methodological Inconsistency

The primary challenge facing the adoption of Intrinsic Capacity as a gold-standard metric is the high degree of methodological inconsistency across the global research community. Because the WHO’s initial definition was designed for policy-level guidance rather than strict clinical trial protocols, it allowed for significant ambiguity. This ambiguity has led to a "Wild West" of IC scoring.

Current studies differ wildly in their scoring approaches, data sources, and the specific measurement tools they employ. For instance, one study might measure the sensory domain using self-reported data on hearing loss, while another uses objective audiometry. In the vitality domain, the discrepancy is even more pronounced; some researchers focus on grip strength and nutritional status, while others prioritize endocrine markers or inflammatory cytokines.

This lack of standardization creates several critical risks:

1. Non-Comparability: It is currently impossible to perform a meta-analysis on IC studies from different regions because the underlying data points are not equivalent.
2. Misinterpretation of Results: Without a standard scale, a "high" IC score in one study might be equivalent to a "moderate" score in another, leading to potentially false conclusions about the efficacy of a treatment.
3. Regulatory Hurdles: For the Food and Drug Administration (FDA) or the European Medicines Agency (EMA) to approve a drug that "slows aging," they require a validated primary endpoint. If IC remains inconsistently measured, it cannot serve as that endpoint.

A Chronology of the Healthy Aging Movement

The evolution of Intrinsic Capacity as a scientific concept has followed a distinct timeline, reflecting the broader maturation of geroscience:

• Pre-2015: The Disease-Centric Era. Research focused almost exclusively on multi-morbidity (the presence of multiple chronic diseases). Health was rarely measured as a standalone positive attribute.
• 2015: The WHO World Report on Ageing and Health. This seminal document introduced the concept of Intrinsic Capacity, shifting the focus from "what people have" (diseases) to "what people can do" (functional capacity).
• 2017: Identification of Subdomains. WHO-affiliated investigators published the five-domain structure (locomotor, cognitive, sensory, psychological, and vitality), providing the first roadmap for clinical application.
• 2019-2022: Global Replication Studies. Large-scale longitudinal studies in Europe (such as the MAPT study), China, and Latin America began testing the IC framework. These studies confirmed that IC scores are powerful predictors of subsequent mortality, nursing home admission, and the incidence of specific diseases like dementia.
• 2023-Present: The Standardization Push. As geroscience enters the era of clinical trials for senolytics and other longevity interventions, the focus has shifted toward creating a unified, operationalizable definition of IC to satisfy regulatory and scientific rigor.

Supporting Data: IC as a Predictor of Mortality

The validity of Intrinsic Capacity is supported by a growing body of empirical evidence. Longitudinal data indicates that a decline in IC often precedes the clinical diagnosis of disease by several years. In a study of over 3,000 older adults, researchers found that individuals with a lower composite IC score at baseline had a 45% higher risk of mortality over a five-year period, even after adjusting for existing chronic conditions.

Furthermore, the vitality domain has shown a particularly strong correlation with biological age. Decreased levels of IGF-1 and DHEAS, combined with low grip strength, have been identified as early warning signs of "frailty syndrome." By measuring these markers collectively under the umbrella of IC, clinicians can identify "pre-frail" individuals who would benefit from early nutritional or exercise interventions before their functional capacity drops below the threshold of independence.

Responses from the Scientific and Clinical Community

The push for standardization has drawn mixed reactions from the global medical community. While there is broad consensus on the utility of the IC framework, many practitioners express concern about the feasibility of implementing comprehensive IC assessments in overstretched primary care settings.

"Intrinsic Capacity is the ‘Holy Grail’ of geriatric assessment," says a researcher involved in the WHO’s Integrated Care for Older People (ICOPE) program. "However, if the measurement process takes two hours and requires expensive lab work for vitality biomarkers, it will never be adopted outside of elite research institutions. We need a ‘lean’ version of IC that is both scientifically rigorous and clinically practical."

On the other side of the spectrum, molecular biologists and geroscience researchers argue that simplifying the metrics too much could strip the framework of its predictive power. They contend that the inclusion of biological vitality markers is essential to distinguish between functional decline caused by aging and decline caused by lifestyle factors or acute illness.

Broader Impact and the Future of Geroscience

The successful standardization of Intrinsic Capacity would have profound implications for the future of public health and the pharmaceutical industry. If health can be measured as a continuous variable, researchers can conduct trials on "healthy" populations to see if a specific intervention can maintain their IC levels over time. This would move medicine away from the current "wait until it breaks" model toward a "maintenance and optimization" model.

Moreover, a standardized IC metric would allow for more equitable global health policies. By using the same "yardstick" to measure health across different countries, international organizations can better identify which populations are aging most successfully and which environmental or social factors contribute to the preservation of intrinsic capacity.

As the field of aging biology moves toward the development of therapies designed to extend "healthspan"—the period of life spent in good health—the need for a clear, operationalizable definition of that health has never been more urgent. The transition from an aspirational goal to a rigorously adhered-to standard will require unprecedented coordination between scientists, clinicians, and regulatory bodies. Without such coordination, the promise of measuring health directly may remain an unfulfilled potential, lost in a sea of incomparable data and inconsistent definitions. The pinning down of health is not merely a technical challenge; it is the essential foundation for the next century of human medicine.